Search

Your search keyword '"Douglas, Nicholas"' showing total 4 results
Start Over Author "Douglas, Nicholas" Language undetermined
4 results on '"Douglas, Nicholas"'

1. Additional file 1: of The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Author

Commons, Robert, Simpson, Julie, Thriemer, Kamala, Chu, Cindy, Douglas, Nicholas, Tesfay Abreha, Sisay Alemu, Arletta Añez, Anstey, Nicholas, Aseffa, Abraham, Ashenafi Assefa, Awab, Ghulam, J. Baird, Barber, Bridget, Borghini-Fuhrer, Isabelle, D’Alessandro, Umberto, Prabin Dahal, Daher, André, Vries, Peter, Erhart, Annette, Gomes, Margarete, Grigg, Matthew, Jimee Hwang, Kager, Piet, Tsige Ketema, Wasif Khan, Lacerda, Marcus, Leslie, Toby, Ley, Benedikt, Kartini Lidia, Wuelton Monteiro, Dhelio Pereira, Phan, Giao, Aung Phyo, Rowland, Mark, Saravu, Kavitha, Sibley, Carol, Siqueira, André, Stepniewska, Kasia, Taylor, Walter, Thwaites, Guy, Tran, Binh, Hien, Tran, Vieira, José, Sonam Wangchuk, Watson, James, William, Timothy, Woodrow, Charles, Francois Nosten, Guerin, Philippe, White, Nicholas, and Ric Price

Subjects
hemic and lymphatic diseases, 3. Good health
Abstract

Checklist 1. PRISMA-IPD. Box 1. Search strategy. Table S1. Studies included in the analysis. Table S2. Reasons for studies not being included in the analysis. Table S3. Studies targeted for the analysis but not included. Table S4. Country of origin and background prevalence of G6PD deficiency in patients with unknown G6PD status. Table S5. Planned primaquine regimens. Figure S1. Study sites for clinical trials. Table S6. Demographics, baseline characteristics and baseline haemoglobin measurements of G6PD normal patients. Table S7. Demographics, baseline characteristics and baseline haemoglobin measurements of patients with unknown G6PD status. Table S8. Comparison of baseline characteristics between included and targeted studies. Table S9. Risk factors for baseline anaemia (Hb 25% leading to development of severe anaemia (Hb 5 g/dL during the first 42 days. Figure S4. Mean haemoglobin versus time profile for patients with or without delayed parasite clearance. Table S14. Unadjusted absolute and percentage change in haemoglobin and risk of anaemia if G6PD deficient. References S1. Studies not included in the analysis. (PDF 1347 kb)

2. Additional file 1: of The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Author

Commons, Robert, Simpson, Julie, Thriemer, Kamala, Chu, Cindy, Douglas, Nicholas, Tesfay Abreha, Sisay Alemu, Arletta Añez, Anstey, Nicholas, Aseffa, Abraham, Ashenafi Assefa, Awab, Ghulam, J. Baird, Barber, Bridget, Borghini-Fuhrer, Isabelle, D’Alessandro, Umberto, Prabin Dahal, Daher, André, Vries, Peter, Erhart, Annette, Gomes, Margarete, Grigg, Matthew, Jimee Hwang, Kager, Piet, Tsige Ketema, Wasif Khan, Lacerda, Marcus, Leslie, Toby, Ley, Benedikt, Kartini Lidia, Wuelton Monteiro, Dhelio Pereira, Phan, Giao, Aung Phyo, Rowland, Mark, Saravu, Kavitha, Sibley, Carol, Siqueira, André, Stepniewska, Kasia, Taylor, Walter, Thwaites, Guy, Tran, Binh, Hien, Tran, Vieira, José, Sonam Wangchuk, Watson, James, William, Timothy, Woodrow, Charles, Francois Nosten, Guerin, Philippe, White, Nicholas, and Ric Price

Subjects
hemic and lymphatic diseases, 3. Good health
Abstract

Checklist 1. PRISMA-IPD. Box 1. Search strategy. Table S1. Studies included in the analysis. Table S2. Reasons for studies not being included in the analysis. Table S3. Studies targeted for the analysis but not included. Table S4. Country of origin and background prevalence of G6PD deficiency in patients with unknown G6PD status. Table S5. Planned primaquine regimens. Figure S1. Study sites for clinical trials. Table S6. Demographics, baseline characteristics and baseline haemoglobin measurements of G6PD normal patients. Table S7. Demographics, baseline characteristics and baseline haemoglobin measurements of patients with unknown G6PD status. Table S8. Comparison of baseline characteristics between included and targeted studies. Table S9. Risk factors for baseline anaemia (Hb 25% leading to development of severe anaemia (Hb 5 g/dL during the first 42 days. Figure S4. Mean haemoglobin versus time profile for patients with or without delayed parasite clearance. Table S14. Unadjusted absolute and percentage change in haemoglobin and risk of anaemia if G6PD deficient. References S1. Studies not included in the analysis. (PDF 1347 kb)

3. Additional file 1 of The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study

Author

Dini, Saber, Douglas, Nicholas, Poespoprodjo, Jeanne, Kenangalem, Enny, Sugiarto, Paulus, Plumb, Ian, Ric Price, and Simpson, Julie

Subjects
3. Good health
Abstract

The file contains details of the developed multi-state model and some additional statistical analyses under the following sections: A. Multi-state modelling of malaria recurrence; B. Episode-specific effects of risk factors; C. Results of univariable analysis; D. Effect modification of species on the rate of events by patients’ age; E. Effect of severity of the initial episode on mortality; F. Re-admission and death multi-state model.

4. Additional file 1 of The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study

Author

Dini, Saber, Douglas, Nicholas, Poespoprodjo, Jeanne, Kenangalem, Enny, Sugiarto, Paulus, Plumb, Ian, Ric Price, and Simpson, Julie

Subjects
3. Good health
Abstract

The file contains details of the developed multi-state model and some additional statistical analyses under the following sections: A. Multi-state modelling of malaria recurrence; B. Episode-specific effects of risk factors; C. Results of univariable analysis; D. Effect modification of species on the rate of events by patients’ age; E. Effect of severity of the initial episode on mortality; F. Re-admission and death multi-state model.

Catalog

Books, media, physical & digital resources
See catalog results